This course is a practical discussion of hot topics in telemedicine law and policy. Audience Q&A will be encouraged, and there will be a strong emphasis on policy approaches and how differences among these new laws and rules affect the marketplace.
Participants will:
- Learn about evolving payment policy for telehealth services (Medicare, Medicaid, commercial insurance state laws, risk-based payments).
- Discuss trends in state medical board telemedicine practice standards, plus the impact of antitrust concerns on the rulemaking process.
- Understand changes to telemedicine-based remote prescribing, including controlled substances, under state law and the Ryan Haight Act.
Serving as a public resource on selected health care legal issues, AHLA educates members, their clients, and local communities on important health law issues. To learn more and register for this event, visit the AHLA conference website.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.